… Figure 2 is based on our practice in treating severe covid-19 pneumonia, and draws largely
… respiratory equipment and outline the rationale for their use in severe covid-19 pneumonia. …

… Coronavirus disease 2019 (COVID-19) is an ongoing pandemic caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first isolated in December 2019 in …

… for patients with severe COVID-19, and immunosuppressive or … of the immunopathogenesis
of severe COVID-19, especially the role … for patients with severe COVID-19 pneumonia. …

… In this phase 3 trial, we randomly assigned patients who were hospitalized with severe
Covid-19 pneumonia in a 2:1 ratio receive a single intravenous infusion of tocilizumab (at a dose …

… severe COVID-19 pneumonia patients admitted to ICU in the Indian population. Material and
methods: A retrospective study was conducted on COVID-19 pneumonia … of COVID-19 were …

… that severe infection caused by the novel Coronavirus … be useful to assist prompt recognition
of severe patients. Should … lymphocyte counts in severe patients suffering COVID-19. The …

… We prospectively enrolled 114 patients with severe COVID-19 who had been discharged
from the hospital after treatment for COVID-19 as inpatients between December 25, 2019, and …

… The objective of this study was to identify clinical and CT features associated with severe/critical
COVID-19 pneumonia by comparing severe/critical patients with ordinary patients. …

… During the 10-day follow-up, three cases of severe adverse events were recorded: two …
In conclusion, our series showed that COVID-19 pneumonia with ARDS was characterized …

… severe COVID-19 infection [5]. The rationale for prolonged, low-dose corticosteroid treatment
in severe COVID-19 … hypoxemic patients with severe SARS-CoV-2 pneumonia who are at …